Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model

• Main Authors: Jacinda C. Abdul-Mutakabbir (Author), Razieh Kebriaei (Author), Kyle C. Stamper (Author), Zain Sheikh (Author), Philip T. Maassen (Author), Katherine L. Lev (Author), Michael J. Rybak (Author)
• Format: Book
• Published: MDPI AG, 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The most efficacious antimicrobial therapy to aid in the successful elimination of resistant <i>S. aureus</i> infections is unknown. In this study, we evaluated varying phenotypes of <i>S. aureus</i> against dalbavancin (DAL), vancomycin (VAN), and daptomycin (DAP) alone and...